AERS II Would Be A Module To Fit Into Umbrella Reporting System, FDA Says
This article was originally published in The Tan Sheet
Executive Summary
FDA now plans to develop the AERS II adverse event reporting system as a module that can eventually be incorporated into an agency-wide system